These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36055119)

  • 21. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
    Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
    Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation.
    Zou XY; Yang HY; Yu Z; Tan XB; Yan X; Huang GT
    Stem Cell Res Ther; 2012 Oct; 3(5):43. PubMed ID: 23095454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of the UAE's first Emirati induced pluripotent stem cell line KUSTi001-A from peripheral blood derived CD34+ hematopoietic cells.
    Azzam SK; Alsafar H; Sajini AA
    Stem Cell Res; 2022 Aug; 63():102853. PubMed ID: 35816920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
    Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
    Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors.
    Mack AA; Kroboth S; Rajesh D; Wang WB
    PLoS One; 2011; 6(11):e27956. PubMed ID: 22132178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficient reprogramming of human cord blood CD34(+) cells for formation of induced pluripotent stem cells with non-integrating plasmid system].
    Zhang QE; Liu SP; Liu YF; Zhang HY; Yuan WP; Chen GB; Li YX; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):728-34. PubMed ID: 23815931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.
    Merling RK; Sweeney CL; Choi U; De Ravin SS; Myers TG; Otaizo-Carrasquero F; Pan J; Linton G; Chen L; Koontz S; Theobald NL; Malech HL
    Blood; 2013 Apr; 121(14):e98-107. PubMed ID: 23386128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of the human erythroblast-derived iPSC line UBTi001-A.
    Avdili A; Rohrhofer L; Auer M; Bernecker C; Schlenke P; Dorn I
    Stem Cell Res; 2022 Oct; 64():102910. PubMed ID: 36103773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic reprogramming of cord blood derived endothelial colony forming cells towards human induced pluripotent stem cells using episomal plasmids.
    Shahid O; Shamim S; Ainuddin JA; Wahid M
    J Pak Med Assoc; 2021 Apr; 71(4):1081-1088. PubMed ID: 34125747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.
    Wen W; Zhang JP; Chen W; Arakaki C; Li X; Baylink D; Botimer GD; Xu J; Yuan W; Cheng T; Zhang XB
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells.
    Gori JL; Chandrasekaran D; Kowalski JP; Adair JE; Beard BC; D'Souza SL; Kiem HP
    Blood; 2012 Sep; 120(13):e35-44. PubMed ID: 22898598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of human erythroblast-derived iPSC line using episomal reprogramming system.
    Varga E; Hansen M; Wüst T; von Lindern M; van den Akker E
    Stem Cell Res; 2017 Dec; 25():30-33. PubMed ID: 29040913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation of Induced Pluripotent Stem Cell (iPSC) Lines from Patient-Specific Peripheral Blood Mononuclear Cells (PBMC) Using Episomal Vectors.
    Konala VBR; Nandakumar S; Surendran H; Pal R
    Methods Mol Biol; 2022; 2549():137-151. PubMed ID: 33772463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
    Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
    Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of human iPSC line NCCSi004-A from umbilical cord blood (UCB) derived CD34
    Fernandes S; Tembe S; Singh S; Vardhan S; Nair V; Kale V; Limaye L
    Stem Cell Res; 2019 Mar; 35():101392. PubMed ID: 30711803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus-free and oncogene-free induced pluripotent stem cell reprogramming in cord blood and peripheral blood in patients with lung disease.
    Kamath A; Ternes S; McGowan S; Moy AB
    Regen Med; 2018 Dec; 13(8):889-915. PubMed ID: 30488785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
    Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
    Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
    Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
    Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.